1,799 results on '"Chin, A."'
Search Results
2. Kruppel-like factor 1–GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo
3. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia
4. IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function
5. Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma
6. CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells
7. Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification
8. Canonical Notch signaling is dispensable for adult steady-state and stress myelo-erythropoiesis
9. An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma
10. Real World Treatment Outcomes for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant in Different Income Countries within Asia Pacific Region
11. A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program
12. How I treat patients with aggressive lymphoma at high risk of CNS relapse
13. Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis
14. Kruppel-like factor 1–GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo
15. Real World Treatment Outcomes for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant in Different Income Countries within Asia Pacific Region
16. Natural killer cell memory precedes HLH in monozygotic twins discordant for chronic active Epstein-Barr virus disease
17. Clinical Features and Mutational Landscape of Patients Referred for Suspected Essential Thrombocytosis: A Descriptive Study Using a 'Real-World’ Database
18. The Practice and Clinical Utility of Trace Metal Testing for Hematology Patients: A Retrospective Cohort Study
19. Safety and Effectiveness of Ruxolitinib in Real-World Patients with Myelofibrosis: A 2-Year Observational Study from Taiwan
20. A Non-Coding Variant in LOC105371512 Confers Susceptibility to Bleomycin-Induced Lung Injury
21. Aged healthy mice acquire clonal hematopoiesis mutations
22. The Practice and Clinical Utility of Trace Metal Testing for Hematology Patients: A Retrospective Cohort Study
23. Safety and Effectiveness of Ruxolitinib in Real-World Patients with Myelofibrosis: A 2-Year Observational Study from Taiwan
24. Clinical Features and Mutational Landscape of Patients Referred for Suspected Essential Thrombocytosis: A Descriptive Study Using a 'Real-World’ Database
25. Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice
26. Functional and Molecular Characterisation of Prospectively Isolated Subclones in Individual AML Patients Reveals Distinct Gene Regulatory Networks Linked to Targetable Metabolic Vulnerabilities
27. In Vitro Drug Studies of Inhibiting MDSC to Improve Efficacy of ICI (immune check point inhibitor) Therapy in Ph(-) myeloproliferative Neoplasm
28. Toxicity Reporting Is Inconsistent and Incomplete, and Subjective Minimizing Language Is Common in Acute Leukemia Clinical Trials: A Systematic Review of Randomized Controlled Trials Presented at ASH between 2017-2021
29. Assessing the Safety of Discharging Patients Receiving High-Dose Methotrexate with Levels Greater Than 0.1 Umol/L
30. Efficacy and Safety of Ropeginterferon Alfa-2b for Pre-Fibrotic Primary Myelofibrosis and DIPSS Low/Intermediate-1 Risk Myelofibrosis
31. A Non-Coding Variant in LOC105371512 Confers Susceptibility to Bleomycin-Induced Lung Injury
32. A Three Gene Leukemic Stem Cell Signature Score Is Robustly Prognostic in Chronic Myelomonocytic Leukemia
33. Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease
34. Effect of Mutation Allele Frequency on the Risk Stratification of Myelodysplastic Syndrome Patients
35. GPC-100 Is a Novel CXCR4 Inhibitor That Leads to Improved in Vitro Potency and In Vivo Efficacy in Stem Cell Mobilization When Combined with a Beta-Blocker
36. Smarca4 (Brg1) Controls Germinal Center B-Cell Development and Is a Haploinsufficient Tumor Suppressor in Lymphoma
37. Dysrangements of TLR-2 in Ph(-) myeloproliferativeneoplasm Related to Jak2 Mutations and Leukocytosis
38. Oncometabolite-Independent Anti-Apoptotic Feature Via Phospholipid Metabolic Adaptation in IDH2 Mutant AML Cells
39. Inconsistent Adverse Event Reporting: A Systematic Review of Phase 3 Lymphoma or Myeloma Trials Presented at ASH Annual Meetings between 2017-2021
40. Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone
41. Prolonged maintenance of hematopoietic stem cells that escape from thrombopoietin deprivation
42. Murine natural killer immunoreceptors use distinct proximal signaling complexes to direct cell function
43. Perivascular support of human hematopoietic stem/progenitor cells
44. CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells
45. Investigating Erythrocytosis: Changing Practice Patterns in the Era of Molecular Diagnostics
46. A Prediction Rule to Guide JAK2 Testing in Patients with Suspected Polycythemia Vera
47. Spectrum of Myeloid Mutations in Patients with Elevated Hemoglobin
48. Dysrangements of TLR-2 in Ph(-) myeloproliferativeneoplasm Related to Jak2 Mutations and Leukocytosis
49. In Vitro Drug Studies of Inhibiting MDSC to Improve Efficacy of ICI (immune check point inhibitor) Therapy in Ph(-) myeloproliferative Neoplasm
50. Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.